Target
Serine/threonine-protein kinase Chk1
Ligand
BDBM402031
Substrate
n/a
Meas. Tech.
Kinase Inhibiting Activity Assay
IC50
0.019±n/a nM
Citation
 Boyle, RGWalker, DWBoyce, RJPeterson, SFarouz, FVo, CH Pharmaceutical compounds US Patent  US10010547 Publication Date 7/3/2018 
Target
Name:
Serine/threonine-protein kinase Chk1
Synonyms:
CHEK1 | CHK1 | CHK1 checkpoint homolog | CHK1_HUMAN | Checkpoint kinase-1 (CHK1)
Type:
Enzyme Catalytic Domain
Mol. Mass.:
54443.02
Organism:
Homo sapiens (Human)
Description:
gi_166295192
Residue:
476
Sequence:
MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASSEENVKYSSSQPEPRTGLSLWDTSPSYIDKLVQGISFSQPTCPDHMLLNSQLLGTPGSSQNPWQRLVKRMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTDRRNNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLIDIVSSQKIWLPAT
  
Inhibitor
Name:
BDBM402031
Synonyms:
5-[[5-[4-[[(3R)-1-isopropylpyrrolidin-3-yl]oxymethyl]-2-methoxy-phenyl]1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile | US10010547, Example 141 | US10973817, Example 141
Type:
Small organic molecule
Emp. Form.:
C23H27N7O2
Mol. Mass.:
433.5062
SMILES:
COc1cc(CO[C@@H]2CCN(C2)C(C)C)ccc1-c1cc(Nc2cnc(cn2)C#N)n[nH]1
Structure:
Search PDB for entries with ligand similarity: